dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

CT Homepage

First ultra high-res CT scan performed on US patient Scanner at UC Davis can image anatomy as small as 150 microns

Trice Imaging connects imaging devices of large chain healthcare provider Aleris Patients and physicians can view images on laptops, cell phones

Industrial hi-res X-ray yields greater insight into child abuse case Identified microscopic injuries that would not have been detected with standard CT

Reducing extravasations in CT contrast-enhanced IV injections Tips and best practices for administering better care

Researchers orchestrate malware attack to expose imaging vulnerabilities Deceived radiologists and AI algorithms into misdiagnoses

House bill would require Medicare to cover CT colonography Supporters say it would improve screening compliance and outcomes

BSWH to install Glassbeam's CLEAN blueprint to leverage machine uptime Will include integrated CMMS software by EQ2

Machine learning reduces false positives for lung cancer in low-dose CT False positives occur at rate of 96 percent

Siemens to unveil its SOMATOM go.Top Cardiovascular Edition CT at ACC 19 Ideal for the cardiovascular outpatient setting

Hitachi unveils new CT and ultrasound solutions at ECR Standard version of SCENARIA VIEW and three new Arietta ultrasound solutions

A new approach combining radiomics
and CT scan assessment may
help determine which lung cancer
patients are most likely to respond
well to chemotherapy

New approach identifies lung cancer patients most likely to respond to chemotherapy

by John R. Fischer , Staff Reporter
Determining who among lung cancer patients is most likely to respond to chemotherapy may soon be possible with a new approach combining CT and radiomics.

Researchers in Cleveland have found that applying radiomics in the assessment of CT images produces quantitative data points showing characteristics of advanced-stage non-small cell lung cancer inside tumors and in the areas around them that are not visible in the images alone and could distinguish those who would respond well to chemotherapy from those that would not.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



"Chemotherapy costs approximately ~ $30,000/patient/year," study author Anant Madabhushi, F. Alex Nason professor of biomedical engineering and director of the Center for Computational Imaging & Personalized Diagnostics at Case Western Reserve University, told HCB News. "Being able to correctly identify patients upfront who are not going to respond to chemotherapy will not only be critical from a patient-centric perspective (i.e. get them on an alternative therapeutic regimen early, one that they are more likely to respond to) but will also save money in unnecessary healthcare costs."

Only one out of four patients responds positively to platinum-based chemotherapy, the usual first-line of treatment against NSCLC. There is no way to predict which patients will benefit the most from the treatment.

The study examined data from 125 patients from Cleveland Clinic who were treated with pemetrexed-based platinum doublet chemotherapy, and were divided randomly into two sets. The training set included 53 patients with NSCLC and had the same number of responders and non-responders, while the validation one had 72.

The authors used a computer to assess the CT scans of lung cancer to identify unique patterns of heterogeneity inside and outside the tumor, and then compared the patterns to images of patients who did and did not respond to chemotherapy. The examination inside the tumor produced an accuracy of 0.68 percent, which increased to 0.77 when combined with an assessment of patterns outside of it. The findings were then fed to a machine learning classifier so that it could identify the likelihood of a lung cancer patient responding to chemotherapy.

In addition to identifying those more likely to respond to chemotherapy, the radiomic features predicted time to progression and overall survival.

Additional steps, however, are required, says Madabhushi. "The data we presented in the work came from a single site and even though the patient cohort was divided into independent testing and training sets, the technology really needs to be validated on scans from an independent site. The other question is to conduct a survey of thoracic oncologists to understand how accurate the technology needs to be (already more than 77 percent accurate) to be clinically useful."

While the basis for the identified radiomic features around the tumor was not widely studied, the researchers hypothesize that their presence indicates an increased fibrotic content in chemotherapy-compliant tumors, and believe that radiomic data derived from CT images could potentially help identify those who carry high risks of recurrence, making it important for them to be carefully observed and examined in follow-up exams.

The findings were published in the journal, Radiology: Artificial Intelligence.

CT Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED